Biosynthetic Technologies names Matthew Kriech as CEO

Biosynthetic Technologies, a developer of biobased and renewable base oils, has appointed Dr. Matthew Kriech as chief executive officer effective immediately. He most recently served as corporate president after a prior stint as chief operating officer.

Kriech brings more than 15 years of experience spanning operational, commercial and research roles within both renewable chemistry and traditional petrochemicals. His doctoral and undergraduate background in chemistry complements oversight around Biosynthetic’s Estolide base oil production technology.

In a statement, Kriech cited excitement accelerating sustainable impact through growing teams, product ranges and overall scale after previously managing areas like supply chain logistics and new market commercialisation. Earlier he directed integration of an acquired oleochemicals manufacturer expanding production capacities.

Kriech takes the CEO reins from founder Thomas Schneider, who transitions into a board member and strategic advisory capacity after more than 25 years guiding Biosynthetic. Observers believe the reshuffle retains continuity around strategy execution leveraging institutional familiarity.

The company focuses on developing safer, higher-performing biobased lubricants and chemicals substituting for conventional variants. Its patented processes convert natural fatty acids from plant oils into specialty ingredients addressing customer demands for reduced environmental impacts.

Its markets span lubricant blending, metalworking, agriculture, personal care and automotive sectors. Strategic emphasis centers on commercialising sustainable technologies as regulatory and social pressures on issues like biodegradability, toxicity and renewability build.

Last year’s addition of commodity oleochemicals manufacturing broadened the availability scale supporting early-stage product adoption beyond developmental quantities as product lines mature.